Neuropathix, Inc. is a biopharmaceutical company. It engages in the research and development of novel new therapeutic agents designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis in 2010 and is headquartered in Doylestown, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Neuropathix Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Neuropathix Inc market cap is $28,100.00.
What is the 52-week high for Neuropathix Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Neuropathix Inc 52 week high is $0.0154 as of September 18, 2025.
What is the 52-week low for Neuropathix Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Neuropathix Inc 52 week low is $0.0002 as of September 18, 2025.
What is Neuropathix Inc stock price today?
Neuropathix Inc stock price today is $0.0003.
What was Neuropathix Inc stock price yesterday?
Neuropathix Inc stock price yesterday was $0.0003.
What is the 50-day moving average of Neuropathix Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Neuropathix Inc 50-day moving average is $0.0003.